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Molecular and Functional Profiling of
Memory CD8 T Cell Differentiation
systems, the mechanisms that determine how and when
these memory T cells develop remain largely unknown.
The differentiation of naı¨ve CD8 T cells into effector
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Ellen Kersh,1 and Rafi Ahmed1,3
1Emory Vaccine Center and Department of
Microbiology and Immunology and memory cells is complex and hence, many funda-
mental questions remain unanswered. CD8 T cell activa-2Department of Pharmacology and the Yerkes
National Primate Center tion spurs a vast chain of events that include activation
of multiple signal transduction pathways, structural re-Emory University School of Medicine
1510 Clifton Road organization of the membrane and cytoskeleton, chro-
matin remodeling and expression of new genes, alter-Atlanta, Georgia 30322
ations in cell adhesion and migration, and induction of
cell division. This transformation is critical for develop-
ing functional effector CD8 T cells that can eliminateSummary
infectious pathogens and for developing long-lived
memory CD8 T cells that can persist in a responsiveHow and when memory T cells form during an immune
state; however, it is not known what the mechanismsresponse are long-standing questions. To better un-
are that drive memory cell differentiation. In addition, thederstand memory CD8 T cell development, a time
developmental lineage that is followed during differentcourse of gene expression and functional changes in
types of immune responses is also not certain. Severalantigen-specific T cells during viral infection was eval-
studies suggest that the lineage of memory CD8 T cellsuated. The expression of many genes continued to
development is linear and memory cells directly de-change after viral clearance in accordance with
scend from effector cells (naı¨ve → effector→ memory),changes in CD8 T cell functional properties. Even
but recent studies have also suggested that activatedthough memory cell precursors were present at the
CD8 T cells can bypass the effector cell stage and devel-peak of the immune response, these cells did not dis-
op into memory cells (Jacob and Baltimore, 1999; Lau-play hallmark functional traits of memory T cells. How-
vau et al., 2001; Manjunath et al., 2001; Oehen andever, these cells gradually acquired the memory cell
Brduscha-Riem, 1998; Opferman et al., 1999). Whetherqualities of self-renewal and rapid recall to antigen
short-lived effector cells and long-lived memory cellssuggesting the model that antigen-specific CD8 T cells
are generated by different developmental programs orprogressively differentiate into memory cells following
whether the same program is utilized but a fraction ofviral infection.
the cells selectively survive and become memory cells
is not clear. Lastly, it has not been carefully determined
Introduction when memory cells arise following antigenic stimulation.
In this study, we have used two distinct but compli-
Development of long-term CD8 T cell memory is an mentary approaches to better understand memory CD8
important goal of vaccination because it can provide T cell differentiation. First, we have tried to uncover
protection against reinfection and disease. This protec- molecular mechanisms involved in memory cell devel-
tion stems from both the increased number of antigen- opment by identifying genes that are differentially ex-
specific CD8 T cells present in an immune host as well pressed in these cells and by analyzing how the pattern
as from the distinct capability of memory CD8 T cells to of gene expression changes as cells transit from effector
proliferate, secrete antiviral cytokines, and kill infected and memory cell stages. Second, we have more pre-
cells more rapidly than naı¨ve CD8 T cells upon exposure cisely defined when memory CD8 T cells form during an
to antigen (reviewed in Dutton et al., 1998; Kaech et al., immune response by examining when antigen-specific
2002). A typical CD8 T cell response to viral infection or CD8 T cells begin to exhibit certain functional properties
vaccination consists of three characteristic phases— characteristic of memory T cells. This combination of
clonal expansion of virus-specific cells and acquisition studies strongly indicated that antigen-specific CD8 T
of effector functions, contraction of the effector cell pop- cells acquire memory cell properties several weeks after
ulation through apoptosis, and generation of a long- virus clearance.
lived population of memory cells (Dutton et al., 1998;
Homann et al., 2001; Kaech et al., 2002; Murali-Krishna Results and Discussion
et al., 1998). The effector cell population is relatively
short-lived as the majority (90%–95%) of these cells Characterization and Purification of P14
die over the weeks following viral clearance. However, Transgenic Naı¨ve, Effector, and Memory CD8 T Cells
the remaining cells that survive generate a long-lived The P14 transgenic mouse strain was used to analyze
population of memory CD8 T cells that is stably main- the changes in gene expression that occur as naı¨ve
tained by steady, yet slow, cell turnover (Jameson, antigen-specific CD8 T cells differentiate into effector
2002). Although the in vivo dynamics of antigen-specific and into memory CD8 T cells. P14 CD8 T cells express
CD8 T cells have been well characterized in several a T cell receptor (TCR) that recognizes the GP33-41
epitope in the LCMV glycoprotein. Naı¨ve P14 CD8 T cells
were obtained directly from the spleens of uninfected3Correspondence: ra@microbio.emory.edu
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Figure 1. Isolation and Characterization of Naı¨ve, Effector, and Memory P14 CD8 T Cells
(A and B) Naı¨ve P14 splenocytes (Thy1.1) were adoptively transferred into C57BL/6 mice (Thy1.2) that were then infected with LCMV. Eight
or 40 days later, P14 CD8 T cells were isolated by FACS using CD8 antibodies and DbGP33-41 MHC class I tetramers (A) or CD8 and
Thy1.1 antibodies (B). Naı¨ve P14 cells were isolated from uninfected P14 mice. The percent of DbGP33-41 cells of CD8 (A) or Thy1.1 CD8
(B) T cell populations prior to cell sorting are indicated in the top images and the percent purity post sorting is indicated in the bottom images
(data are representative of at least three separate cell isolations). The bottom image in (B) shows that nearly all (95%) of the sorted Thy1.1
CD8 T cells are antigen-specific (DbGP33-41 tetramerve)
(C) The levels of surface CD44, CD62L (L-selectin), CD122 and CD43 for naı¨ve (filled), d8 effector (thick line), and memory (thin line) DbGP33-
41 P14 CD8 T cells are shown.
(D) Naı¨ve, d8 effector, and memory P14 splenocytes were stimulated for 5 hr with GP33-41 peptide followed by staining for CD8 and IFN-.
The percent of CD8 T cells producing IFN- is indicated. Note that 100% of the effector and memory P14 CD8 T cells produce IFN-.
(E) The direct ex vivo CTL activity of naı¨ve (circle), d8 effector (square), and memory (day 40 p.i., open triangle) P14 CD8 T cells after 5 hr
chromium-release assay. Cultures were normalized to contain equal numbers of P14 CD8 T cells.
(F) Granzyme B levels in purified naı¨ve, d8 effector, or memory P14 CD8 T cells were detected using Western blotting.
P14 mice, whereas effector and memory P14 CD8 T cells not immediately cytotoxic ex vivo and did not contain
high levels of Granzyme B (Figures 1C–1F).were generated by adoptive transfer of either Thy1.2 or
Thy1.1 P14 splenocytes into C57BL/6 (Thy1.2) mice
that were subsequently infected with LCMV-Armstrong. Gene Expression Profile of Effector CD8 T Cells
To analyze the first phase of CD8 T cell differentiationPure populations of “resting” naı¨ve, effector, and mem-
ory P14 CD8 T cells were isolated using FACS based (naı¨ve→ effector CD8 T cell), gene expression patterns
were compared between naı¨ve and d8 effector P14 CD8on either (1) CD8 and DbGP33-41 MHC class I tetramer
or (2) CD8 and Thy1.1 staining (Figure 1). T cells on DNA microarrays from Incyte Genomics and
Affymetrix that contain 8,700 and 12,400 murineEffector CD8 T cells were isolated eight days postin-
fection (d8 p.i.), at the peak of the effector CD8 T cell genes, respectively. The relative abundance of specific
transcripts from each cell type was quantitated and aresponse, and memory CD8 T cells were isolated at least
40 days p.i. Naı¨ve P14 CD8 T cells were CD44lo, CD62Lhi, differential expression ratio was calculated. Genes that
had been previously identified or were highly similarCD122lo, and CD43lo and did not immediately produce
IFN- or cytotoxic molecules, whereas d8 effector cells to known genes were putatively assigned to functional
categories (Table 1). An expanded version of Table 1were CD44hi, CD62Llo, CD122hi, and CD43hi, rapidly se-
creted IFN-, were highly cytotoxic in direct ex vivo and the remaining ESTs and unassigned genes can be
found in the Supplemental Data, Tables S1–S3, availableassays, and contained high levels of Granzyme B (Fig-
ures 1C–1F). Memory P14 CD8 T cells were CD44hi, at http://www.cell.com/cgi/content/full/111/6/837/DC1.
The genes identified in these experiments revealed sev-mostly CD62Lhi (60%–95% are CD62Lhi), CD122hi, CD43int,
and rapidly produced IFN- upon restimulation, but were eral traits of effector CD8 T cells; some are novel and
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some are similar to those previously described by sepa- and PEP phosphatase; (2) intracellular Ca2 signaling,
rate gene expression studies on polyclonal populations such as calcyclin, calcineurin catalytic subunit, annexin
of activated T cells (Liu et al., 2001; Teague et al., 1999). A2 and A6, and Ca2 transporting ATPases; and (3) cyto-
As naı¨ve CD8 T cells differentiate into effector cells, kine signaling, such as JAK1, STAT4, and SOCS-5. A
they acquire the ability to migrate from lymphoid to non- corollary increase in lck and fyn protein in effector cells
lymphoid tissues and this is largely attributed to the was observed by intracellular staining (see Supplemen-
increased cell surface levels of chemokine receptors tal Data, Figure S1 available at above website). In-
and cell adhesion molecules (for review, see Moser and creased expression of the genes that act positively in
Loetscher, 2001). We observed that genes encoding these signaling pathways may enhance signal transduc-
chemotactic proteins CCR2, CCR5, neuropilin, and sem- tion, alleviate the dependence on costimulation, or lead
aphorin 4D, and cell adhesion proteins MAC-2, CD11c, to faster responses to antigen than that observed in
CD18, CD44, and P-selectin ligand were increased in naı¨ve cells (Dutton et al., 1998; Iezzi et al., 1998). How-
effector CD8 T cells (Table 1, Cell adhesion and migra- ever, negative regulation of TCR and cytokine signaling
tion). The concerted action of these molecules can per- was also evident because expression of PEP phospha-
mit effector cells to migrate toward sites of inflammation, tase and SOCS-5 was increased and expression of the
adhere to the endothelial cell linings, and extravasate IL-4, IL-7, and IFN- receptor  chains was decreased.
into tissues. A corollary increase in surface protein levels Several genes that regulate actin polymerization were
was observed in effector CD8 T cells for several of these increased in effector CD8 T cells, including members of
genes (see Supplemental Data, Figure S2 available at the ARP2/3 complex, talin, filamin, and cdc42 rho
http://www.cell.com/cgi/content/full/111/6/837/DC1). GTPase (see Table 1, Cytoskeleton regulation). These
The expression of lymph node homing proteins, such gene products may be important for the increased for-
as L-selectin (CD62L) and CCR7 also regulate effector mation of actin-based structures found in effector CD8
cell migration because their expression is reduced on T cells, such as filopodia and lipid raft microdomains
effector CD8 T cells and thus, their ability to migrate to that could lead to increased cell motility and signaling,
the lymph nodes is compromised. L-selectin expression respectively. This is similar to previous reports showing
can be regulated by both transcriptional and posttran- that activated CD8 T cells have higher actin and lipid
scriptional mechanisms such as proteolytic cleavage raft content than naı¨ve cells (Liu et al., 2001; Tuosto et
after TCR activation (Chao et al., 1997). L-selectin mRNA al., 2001).
levels were depressed 10-fold in d8 effector CD8 T We observed that several genes involved in protein
cells compared to naı¨ve cells, indicating that transcrip- translation, such as ribosomal proteins S5, P2, L23, S15,
tional repression of L-selectin occurs in vivo. Conse- and L35 were reduced in effector CD8 T cells (Table
quently, nearly all (95%–99%) of the d8 effector cells 1, Protein degradation, modification and translation).
display low surface levels of L-selectin as observed by Perhaps, this represents a general reduction in transla-
flow cytometry (Figure 1C). It remains to be determined tion that may contribute to the effector cell apoptosis
when this locus becomes silenced following infection that will occur over the proceeding days. Additionally,
and why two mechanisms exist to decrease L-selectin a decrease in cytokines coincides with viral clearance
levels, but together these data highlight the importance and this deprivation may induce an energetic crisis that
of maintaining low L-selectin levels on effector cells. leads to decreased protein synthesis (Rathmell et al.,
The mRNAs of several other membrane-spanning or 2001).
GPI-linked proteins, whose functions have not been fully Finally, a few genes predicted to impact mitochondrial
defined, were increased in effector cells; these included function were differentially expressed between effector
CD97, Ly116 (chandra), Glvr-1 and Ly-6A/E, Ly-6C, and and naı¨ve CD8 T cells, possibly illuminating differences
Thy-1 (Table 1, Membrane proteins). The role of Ly-6C in their respiratory capacity. Genes encoding several
and Ly-6A/E in T cell function is not clear and interest-
glycolytic enzymes, the mitochondrial uncoupling pro-
ingly, the responses of T cells deficient of GPI-linked
tein 2, and glutathione reductase were upregulated in
proteins including Thy-1, Ly-6A, and Ly-6C did not ap-
effector cells as well as genes encoding three subunitspear to be affected in vitro or in vivo (Takahama et al.,
of mitochondrial complex I NADH dehydrogenase (Table1998).
1, Energy metabolism).Killing of infected cells is a critical effector CD8 T cell
In summary, the above data confirm that multiple cel-function that is mediated by the release of perforin and
lular processes are involved in the differentiation of naı¨vegranzymes. Expression of perforin and granzymes A, B,
CD8 T cells into effector cells. Most notably, genes in-D, and K mRNA was highly elevated in effector CD8 T
volved in signal transduction, actin regulation, cell adhe-cells compared to naı¨ve cells (Table 1, T cell effector
sion/migration, and translation were altered during effec-functions). For granzyme B, this correlated with in-
tor cell development. Finally, given the recent attentioncreased protein levels as observed by Western blotting
of L-selectin expression on subsets of antigen-specific(Figure 1F). The expression levels of other CD8 T cell
CD8 T cells, this study found that reduced surface ex-effector molecules, such as IFN-, RANTES, and Fas
pression of L-selectin correlated with decreased mRNAligand were also increased (Table 1).
levels in effector CD8 T cells.We also observed that the mRNA levels of many genes
encoding signaling molecules were elevated in effector
Memory CD8 T Cell Gene Expression ProfileCD8 T cells. Most of these genes could be placed into
During the second phase of a CD8 T cell immune re-several well-characterized signal transduction path-
sponse, the majority of the effector cells die, but thoseways—(1) TCR signaling, such as CD45 phosphatase,
grb-2, lck, fyn, lck-interacting adaptor protein (LIME), that survive constitute the pool of memory cells. Memory
Cell
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cells are qualitatively distinct from naı¨ve cells and can cell recall responses. This may also contribute to why
proliferate and acquire effector functions much more memory CD8 T cells can persist in the absence of MHC
rapidly upon exposure to antigen. Also, memory cells, class I interactions and rely less on costimulation for
in contrast to naı¨ve cells, undergo a slow antigen-inde- activation than naı¨ve cells (Dutton et al., 1998; Jameson,
pendent homeostatic proliferation to maintain their 2002).
numbers in the periphery. To better understand these A unique property of memory CD8 T cells is homeo-
functional differences, the gene expression profile of static proliferation that can replenish the pool of memory
memory CD8 T cells was compared to naı¨ve cells and cells. We found several cell cycle genes upregulated in
the results of this comparison are shown in Table 1 and memory CD8 T cells such as cyclin E1, E2, and B1 (Table
Supplemental Data (available at http://www.cell.com/ 1, Cell cycle). The gene encoding telomerase binding
cgi/content/full/111/6/837/DC1). This study revealed protein p23 was also upregulated which supports our
sets of genes and potential pathways that may be impor- findings that resting LCMV-specific memory CD8 T cells
tant for generating memory cell phenotypes as well as contain telomerase activity in vivo (Hathcock et al.,
confirmed features of memory CD8 T cells that have 2003). Lastly, IL-15 is required for memory cell homeo-
been previously recognized. static proliferation, and in accordance, memory cells
Recently, it has been observed that memory CD8 T expressed the IL-15R chain1.5-fold higher than naı¨ve
cells reside in both lymphoid and non-lymphoid tissues, cells. This is similar to that reported by Goldrath et al.
and hence, several of the genes involved in cell migration (2002) and correlates with increased protein levels on
and adhesion that were upregulated in effector cells memory cells (Schluns et al., 2002).
were also increased in memory cells (Table 1); this in- The expression of several genes encoding effector
cluded CCR2, CCR5, the semaphorin ligand neuropilin, molecules such as IFN-, fas ligand, RANTES, MIP-1,
CD44, CD18, CD11c, and glycam-1. However, CXCR4 perforin, and granzymes B, K, and M were substantially
was selectively upregulated in memory CD8 T cells as higher in memory cells than in naı¨ve cells (Table 1).
compared to effector cells and may indicate that mem- Interestingly, for granzyme B, this expression profile did
ory CD8 T cells are inclined to migrate toward stromal- not correlate with significant increases in protein as
cell derived factor-1 (SDF-1) expressing cells. In addi- compared to d8 effector cells (Figure 1F). The uncou-
tion, L-selectin (CD62L) mRNA was reduced 2-fold in pling of transcription from translation has also been ob-
memory CD8 T cells compared to naı¨ve cells, but this served for IFN- and IL-2 in antigen-specific CD8 T cells
was significantly less than the 10-fold decrease ob- and may signify a general mechanism to simultaneously
served in effector cells. This observation suggested that maintain memory CD8 T cell preparedness while pre-
transcription was reinitiated at the L-selectin locus as venting the improper release of cytotoxic and inflamma-
effector cells differentiated into memory CD8 T cells. tory molecules (Bachmann et al., 1999; Grayson et al.,
Recently, functional differences between the CD62Llo 2001; Slifka et al., 1999; Veiga-Fernandes et al., 2000).
and CD62Lhi subsets of memory CD8 T cells have re- In summary, several genes involved in signal trans-
ceived much attention, but it is not clear how these duction, cell migration, and cell division are differentially
different subsets are generated (Masopust et al., 2001; regulated in memory CD8 T cells as compared to naı¨ve
Reinhardt et al., 2001; Sallusto et al., 1999). This study CD8 T cells. Furthermore, in combination with recent
suggests, however, that during LCMV infection the precur- studies, our results confirm that the mRNA expression
sors of the CD62Lhi subset of memory CD8 T cells transit of key effector molecules (i.e., granzyme B and IFN-)
through a CD62Llo state because nearly all the LCMV- is constitutive in memory CD8 T cells but that production
specific CD8 T cells exhibit low levels of both L-selectin of the protein is regulated by antigen contact and this
mRNA and protein d8 p.i. (Figure 1 and Table 1). may facilitate rapid memory cell recall responses. Fi-
The two most highly differentially expressed genes in nally, these studies show that several genes continue
memory CD8 T cells compared to naı¨ve cells encode
to be differentially expressed in memory CD8 T cells,
family members of the GPI-linked proteins Ly-6C and
as compared to naı¨ve cells, and illuminate that following
Ly-6A/E. Likewise, these proteins are expressed at very
the effector cell stage, gene expression patterns arehigh levels on memory CD8 T cells (see Supplemental
permanently altered in antigen-specific memory CD8 TData, Figure S1 available at http://www.cell.com/cgi/
cells.content/full/111/6/837/DC1). As previously mentioned, the
role of these proteins in memory T cell function is unclear
Comparison of Effector and Memory CD8 T Celland requires further study.
Gene Expression ProfilesSeveral genes involved in signal transduction were
Since effector and memory P14 CD8 T cells were com-elevated in memory CD8 T cells. Indeed, the expression
pared to the same reference naı¨ve P14 CD8 T cell popu-of some of these genes were similarly increased in ef-
lation, the similarities and differences between effectorfector cells, such as calcyclin, fyn, lck, racGAP1, LIME,
and memory cell gene profiles could be assessed byPEP phosphatase, annexin A2 and A6, and STAT4 (see
aligning the differentially expressed genes. This createdTable 1); however, other genes were preferentially found
a set of 350 genes that were differentially expressedin memory CD8 T cells, such as members of the p38
at least 1.7-fold in either effector or memory CD8 T cellsand jun kinase (JNK) signaling pathways MKK4, Ier-2,
as compared to naı¨ve cells. Of this set of genes, 30%junB, fos, and ATF-2. Recent antigen contact is an un-
were commonly upregulated in both effector and mem-likely cause of the increased expression of these genes,
ory CD8 T cells (see Table 1 and Supplemental Data,but growth factors, cytokines, or other stimuli may play
Figure S2 and Table S4, available at http://www.cell.a role. Elevation of signal transduction proteins may
increase sensitivity to TCR signals and expedite memory com/cgi/content/full/111/6/837/DC1). This implied that
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many of the gene regulatory changes that occurred dur- 6b, Figure 2). Other examples include CXCR4, several
ribosomal protein genes (P2, S5, S15, and L39), and theing effector cell development were maintained in mem-
ory cells and supported the model that a direct lineage forkhead transcription factor FKHR.
exists between effector and memory CD8 T cells. Sec-
ond, closer examination of the differential expression Progressive Development of Memory CD8
ratios revealed that the magnitude of expression was T Cell Properties
commonly greater in effector cells than in memory cells Identification of Memory Cell Precursors
which implied that effector cells may be more transcrip- at d8 Postinfection
tionally active (compare in Table 1). Third, and perhaps Because the expression pattern of many genes contin-
most important, subsets of genes were found to be ued to change following the peak of the CD8 T cell
preferentially expressed in either effector or memory response (d8 p.i.), this led us to consider when are mem-
cells (e.g., actin regulators and cell cycle genes, respec- ory CD8 T cells being generated? This gene expression
tively). The appearance of effector or memory-specific data may suggest that the virus-specific CD8 T cells
genes suggests that memory CD8 T cells are not simply continue to differentiate and coordinately acquire mem-
“resting effectors” but are a distinct cell population. ory cell attributes over the weeks following viral clear-
This interpretation invoked the model that memory cell ance and proposes the model that functional, long-lived
development occurs in two stages; a first phase where memory cells develop several weeks postinfection. This
naı¨ve cells differentiate into effector cells, followed by is in contrast with the model that memory CD8 T cells
a second phase where effector cells differentiate into are generated simultaneously with effector cells and
memory CD8 T cells. exist by the peak of the CD8 T cell response. To examine
these models more closely, we first inspected whether
virus-specific CD8 T cells that can give rise to memoryChanges in Gene Expression between Effector
and Memory Cell Stages CD8 T cells exist by d8 p.i. As shown in Figure 3, LCMV-
specific CD8 T cells were purified at d8 p.i., labeled withThe above proposal led us to examine how gene expres-
sion patterns change over the weeks following infection CFSE, and transferred into naı¨ve mice. The kinetics of
effector cell contraction in the recipients mirrored thatwhen memory cells form. Thus, P14 CD8 T cells were
isolated at the peak of the immune response (d8 p.i.), seen normally; that is, 50%–70% of the donor cells
died within the first week and10%–20% became long-during the death phase (d15 and d22 p.i.), and after
formation of a memory CD8 T cell population (d40 p.i.). lived memory cells by one month posttransfer. The
memory cells that arose from the transferred d8 effectormRNA from these populations was compared to that of
naı¨ve P14 cells to identify genes that were differentially CD8 T cells were indistinguishable from those generated
normally based on expression of surface markers andexpressed during this time period. A K-means clustering
algorithm was used to identify coordinately regulated cytokines and could protect against viral rechallenge
with the virulent strain of LCMV-clone 13 (Figure 3B andgenes and six major patterns were observed (Figure 2).
Several of the genes placed into each group are listed data not shown; Kaech and Ahmed, 2001). In combina-
tion with similar results from other antigenic systems,in Table 2, but a complete list can be found in the Supple-
mental Data (Table S6 available at http://www.cell.com/ these data strongly indicate that precursors to memory
CD8 T cells exist early during an infection (Hu et al.,cgi/content/full/111/6/837/DC1). In the first group, the
expression levels of many genes (60%) were set at d8 2001; Jacob and Baltimore, 1999; Opferman et al., 1999;
Voehringer et al., 2001).p.i. and did not significantly change over the following
weeks; this suggested that most gene regulatory It is possible that the memory CD8 T cell population
is generated by a few precursor cells that expand whilechanges imprinted during effector cell differentiation are
maintained in memory cells. The second group (Groups the effector cells disappear following viral clearance.
This idea was investigated by examining the level of2a and 2b, Table 2) contained genes that tended to be
most highly expressed at d8 p.i., but their expression CFSE fluorescence in the transferred d8 effector popula-
tion 1, 11, and 30 days after transfer (Figure 3C). Interest-gradually decreased over the next several weeks to the
level in memory cells. Perhaps, this reflects a global ingly, we observed minimal to no division of this cell
population within one months time; more than 90% ofreduction in transcriptional activity associated with
memory CD8 T cell development. This group included the memory cells generated from the transferred d8 pop-
ulation had not divided (Figure 3C). This showed thatgranzyme B, CCR2, CD11c, Ly-6C, and Ly-6A/E. Group
3 displayed genes that remained downregulated in anti- the memory CD8 T cell population does not arise from
a small subset of effector cells that expand during thegen-specific CD8 T cells following infection and in-
cluded the transcription factor LEF-1, T cell-specific death phase. Rather, the memory CD8 T cells descend
directly from effector cells. This is similar to that recentlyGTPase, and sialytransferase-1. Groups 4, 5, and 6 in-
cluded genes that displayed more dynamic patterns reported for development of the memory CD4 T cells
(Hu et al., 2001).during the effector to memory transition period. In group
4, the gene expression levels showed minimal change It has not been carefully determined when fully func-
tional memory CD8 T cells develop during an immuneat d8 but then increased at days 15–22 p.i., whereas in
groups 5 and 6 the expression levels initially decreased response. The above results indicated that cells present
8 days p.i. have the potential to generate a stable andduring this interval and then increased as the memory
CD8 T cell population was stabilized. A key example protective memory cell population, but do these cells
display functional properties ascribed to memory CD8was the change in L-selectin (CD62L) expression that
steadily increased from d8 to day 40 p.i. (see Group T cells? To better delineate when memory cells are
Cell
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Figure 2. Repatterning Gene Expression between Effector and Memory Cell Stages
The gene expression profiles of P14 CD8 T cells isolated 8, 15, 22, and 40 days p.i. were compared to naı¨ve cells. Genes with coordinated
expression patterns were grouped as determined by K-means algorithm using 10 estimated sets and six representative patterns are presented.
Scales to left of graphs indicate expression levels. Genes were selected for analysis if their average expression level deviated from that of
naı¨ve cells by at least a factor of 1.7 in at least one of the time points and gave reproducible measurements across multiple hybridizations
(431 genes met this criteria).
formed, we examined when virus-specific CD8 T cells days later (Figure 3D). As expected, memory CD8 T
cells from d40 p.i. divided substantially within the monthbegan to exhibit two quintessential memory cell quali-
ties—the ability to proliferate in response to homeostatic whereas cells from d8 p.i. divided minimally. Interest-
ingly, cell division was seen in the population of cellssignals and the ability to rapidly proliferate and survive
in response to antigenic signals. transferred from d15 and d22 p.i., demonstrating that
between days 15–22 p.i. antigen-specific CD8 T cellsImpaired Homeostatic Proliferation in Effector
CD8 T Cells acquire the property to undergo homeostatic prolifera-
tion. This indicated that at d8 p.i., the memory cell pre-Memory CD8 T cells can undergo homeostatic prolifera-
tion that is regulated by cytokines such as IL-15 and cursors are initially unresponsive to homeostatic prolif-
erative signals, but over the next 2–3 weeks they becomeIL-7 (Jameson, 2002). As shown in Figure 3C, the d8
effector cell population showed minimal to no prolifera- responsive. Effector and memory cells display similar
levels of IL-15R chain; therefore, this may not accounttion after transfer into naı¨ve mice suggesting that mem-
ory cell precursors present at d8 p.i. cannot respond to for their proliferative differences (Schluns et al., 2002).
Thus, in accordance with changes in gene expression,homeostatic proliferative signals as effectively as mem-
ory CD8 T cells present 40 days p.i. To examine when the ability to proliferate to homeostatic signals is gradu-
ally acquired over the weeks following viral clearance.following infection the antigen-specific CD8 T cells be-
gin to proliferate in response to homeostatic signals, Impaired Effector CD8 T Cell Proliferation
and Survival in Response to AntigenP14 CD8 T cells from d8, d15, d22, and d40 p.i. were
CFSE-labeled and transferred into non-irradiated naı¨ve Another salient memory T cell trait is their high prolifera-
tive potential in response to antigen. Upon secondarymice and the extent of cell division was examined 30
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Table 2. Coordinate Regulation of Gene Expression during Memory CD8 T Cell Development
Accession
Groupa Number Gene Name Description d8 p.i. d15 p.i. d22 p.i. d40 p.i.
2a AA289476.1 CCR2 cell migration 11 11.8 12 6.5
AA000712.1 Ly-6C membrane protein 15.8 9.4 9.2 12.4
AA183327.1 Granzyme B cytolysis 15.4 9.3 11 4.9
AA178276.1 CD11c cell adhesion 8.7 7.2 6.9 3
AA145865.1 Ly-6A/E membrane protein 8.5 6.6 6.6 7.2
AA472994.1 sim to Ly6A/E membrane protein 8.2 5.1 5.1 6.4
AA267952.1 Calcyclin Ca signaling 7.7 4.9 5.3 6.1
2b AA265396.1 Stathmin cytoskeleton regulation 4.8 1.9 2.6 2.1
W62969.1 Fyn signal transduction 2.8 1.8 1.9 2.1
AA161823.1 Ly116/CHANDRA membrane protein 3.1 1.9 1.9 2
W89518.1 Annexin A2 Ca signaling 4.8 2.3 3 1.9
AA467489.1 CD18 (beta-integrin) cell adhesion 2.8 2.1 2.3 1.8
AA146265.1 EST 2.9 1.9 1.9 1.8
W82294.1 EST 2.9 1.6 1.7 1.8
AA140523.1 rac-GAP signal transduction 2.5 1.9 2.2 1.7
AA245492.1 EST 5.3 1.7 2.2 1.7
AA173013.1 Spi12 proteinase inhibitor ser. protease inhibitor 3.4 2.1 1.9 1.6
AA475311.1 P-selectin ligand cell migration 2.4 1.7 1.6 1.6
AA008417.1 Dok2 signal transduction 1.9 1.8 2 1.5
AA276837.1 EST 2.8 2.2 2.1 1.4
AA403841.1 Galectin-3 cell adhesion 2.6 1.9 2.2 1
3 W87149.1 p53 1.2 1.6 1.7 1
AA268148.1 eEF-1b2 translation 2.2 1.4 1.5 1
AA444490.1 TIMP2 metalloproteinase inhibitor 1.4 1.9 2.1 1.2
AA221110.1 60S ribosomal protein L35A translation 2 1.4 1.6 1.3
AA276764.1 Integrin alpha E cell adhesion 1.2 2.1 2.4 1.3
AA261454.1 EST 1.4 2.4 2.7 1.3
AA118626.1 EST 1.8 3.1 3.2 1.5
AA008222.1 Smoothened homolog signal transduction 1.7 1.3 1.1 1.6
AA509565.1 T cell specific GTPase signal transduction 2.2 1.6 1.2 1.7
AI323095.1 sialytransferase 1 glycosylation 2 1.9 1.7 1.7
AA098196.1 IgA heavy chain C region 1.4 2.2 1.9 1.8
AA521593.1 EST 1.8 1.2 1.2 1.9
AA119479.1 LEF-1 gene expression 2.3 3 3 1.9
AA272807.1 MHC class II I-A  chain 1.9 1 1.2 2.6
4 AI893893.1 CIS1/SOCS cytokine signaling 1 1.5 2.2 1.7
AA437891.1 EST 1.1 2.2 1 1.6
AA108880.1 Ca channel -subunit Ca signaling 1 2 2.6 1.4
AA212893.1 EST 1 2.7 1 1.4
AA521764.1 RAMP-2 regulates calcitonin receptor 1 2 1.5 1
AA060880.1 EST 1 4.7 3.4 1
AA177218.1 EST 1 2.3 1.5 1
5 W18484.1 MEL91 signal transduction 1.5 3.3 4.5 1.8
AA007970.1 stannin detoxification 1.3 1.8 2.3 1.5
AA014889.1 sim to alpha 1,2-mannosidase 1.4 2.1 2.8 1.4
AA178361.1 Lysosomal acid lipase 1 1 2.6 3.9 1.4
W99918.1 EST 1.3 2.4 3.6 1.3
6a W88094.1 CXCR4 cell migration 1 1.7 1.3 1.7
AA080443.1 EST 1 1 2.1 1.6
AA097980.1 Cytochrome P450 detoxification 1 1 2.3 1.6
AA068750.1 SDF-1 cell migration 1.2 1 1.9 1.4
AA047991.1 60S ribosomal protein P2 translation 1.7 1.1 1.2 1.3
AA073904.1 Dickkopf-3 signal transduction 1 1 2.5 1
AA240279.1 40S ribosomal protein S5 translation 1.7 1 1.3 1
W36356.1 Forkhead (FKHR) gene expression 1 1.7 1.7 1
W41682.1 Glucosamine fruct.-6-PO4 hexosamine pathway 2.1 1.5 1.7 1
transaminase
W65070.1 EST 2.5 1.5 1.7 1
AA033398.1 40S ribosomal protein S15 translation 1.9 1.3 1.4 1
AI604200.1 60S ribosomal protein L39 translation 1.8 1.6 1.6 1
6b AA183698.1 L-selectin (CD62L) cell migration 9.6 5.3 3.9 2
W82894.1 EST 4.3 4.5 4.1 2.7
a Groups according to those outlined in Figure 2.
Group 1 list of genes and an expanded table can be found in Supplemental Data, Supplemental Table S6 available at http://www.cell.com/
cgi/content/full/111/6/837/DC1.
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Figure 3. Memory Cell Precursors Exist by d8 p.i. but Have Not Acquired the Ability to Proliferate to Homeostatic Signals
(A) P14 CD8 T cells were purified at d8, 15, 22, and d40 p.i., labeled with CFSE, and transferred into non-irradiated naı¨ve B6 mice and the
extent of cell division was examined at later time points.
(B) The number of d8 effector or d40 memory cells present 7 and 35 days posttransfer are shown as a percentage of donor cells present
one day after transfer. Note that the number of transferred memory CD8 T cells remains relatively constant, but the number of d8 effector
cells contracts similar to that observed normally between days 8–30 p.i.
(C) The extent of cell division, based on CFSE fluorescence, in the d8 effector and d40 memory cells was examined 1, 11, and 30 days
posttransfer. Histograms displaying CFSE fluorescence are gated on DbGP33-41 CD8 P14 T cells.
(D) P14 CD8 T cells from d8, d15, d22, and d40 p.i. were CFSE-labeled and transferred into naı¨ve mice and cell division was examined 30
days later as described in (C).
contact with antigen, memory CD8 T cells divide rapidly Every week after adoptive transfer serum viral titers were
quantitated. In carrier mice that received adoptive im-and extensively to generate a second burst of effector
cells. Therefore, we examined when following an acute mune therapy using memory CD8 T cells, viral titers
plummeted within two weeks and were maintained atviral infection antigen-specific CD8 T cells display a
memory cell-like proliferative capacity in response to undetectable levels (Figure 4B). In contrast, carrier mice
that received adoptive immune therapy using cells fromantigen.
First, we compared the capacity of P14 CD8 T cells d8 p.i., viral titers initially decreased, indicating effector
functions were intact, but virus was not controlled andfrom mice infected 8, 15, 22, or 40 days previously to
proliferate to antigen in vitro. P14 CD8 T cells were levels eventually returned to that seen prior to transfer
(Figure 4B). A similar outcome was observed when d14labeled with CFSE and stimulated with antigen-present-
ing cells (APCs) pulsed with GP33-41 peptide for 72 hr. cells were transferred (Figure 4D). d22 cells, on the other
hand, could control the virus in most carrier mice, butThis showed that memory P14 CD8 T cells (d40  p.i.)
divided the most extensively, whereas d8 and d15 cells not all (data not shown). If d8 and memory cells were
cotransferred into carrier mice, the virus was cleareddivided the least and d22 cells showed an intermediate
pattern (Figure 4A). The progeny of stimulated memory rapidly, thus, eliminating the possibility that a second
population of “regulatory” cells existed at d8 p.i. thatcells (d40  p.i.) also survived better in culture than did
those of d8 effector cells. Typically, cultures containing inhibited effector CD8 T cell function (Figure 4B). In
summary, these experiments demonstrate that d8 andmemory P14 CD8 T cells expanded 6-fold, whereas
those containing d8 cells dropped 3-fold despite the d15 effector CD8 T cells do not sustain effector functions
as well as memory CD8 T cells (d40  p.i.) in responseobserved proliferation (data not shown). These results
indicated by d40 p.i., and to an extent by d22 p.i., the to antigen in vivo.
The inability of d8 effector cells to control viremia maycapacity of LCMV-specific CD8 T cells to extensively pro-
liferate and survive when stimulated in vitro has increased, be largely attributed to decreased proliferation in carrier
mice. Equal numbers of d8 effector and memory Thy1.1but these qualities had not developed by d15 p.i.
To determine if a similar phenomena occurred in vivo, LCMV-specific CD8 T cells were labeled with CFSE,
independently transferred into Thy1.2 LCMV carrierCD8 T cells from mice infected 8, 14, 22, and 40 days
previously were transferred into LCMV carrier mice that mice, and examined 4 and 7 days later. Within this time,
the memory CD8 T cells expanded significantly and werehave been persistently infected with LCMV since birth.
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Figure 4. Responses of LCMV-Specific CD8 T Cells to Antigen during Memory CD8 T Cell Development
(A) P14 CD8 T cells were isolated at the indicated times after infection, labeled with CFSE, and stimulated with GP33-41 peptide for three
days in vitro. Cells were stained with CD8 antibodies and DbGP33-41 tetramers and CFSE fluorescence was analyzed by flow cytometry.
Histograms displaying CFSE fluorescence are gated on DbGP33-41 CD8 T cells.
(B) The kinetics of viral clearance in LCMV carrier mice that received adoptive immune therapy. Splenocytes containing memory CD8 T cells
(d40 p.i., top) or effector CD8 T cells (d8 p.i., middle) or both (bottom) were transferred into carrier mice and serum viral titers were determined
by plaque assay at the indicated times posttransfer. Viral titers in untreated LCMV carrier mice are shown (open squares). Dashed line indicates
threshold of detection.
(C) LCMV-specific CD8 T cell proliferation in carrier mice. 1  106 Thy1.1 LCMV-specific CD8 T cells from d8 (top) or d40 infected mice
(bottom) were CFSE-labeled and transferred into Thy1.2 carrier mice and four and seven days later their expansion was examined. Dot plots
are gated on Thy1.1 cells. Numbers of DbGP33-41-specific CD8 T cells per spleen are indicated.
(D) The number of LCMV-specific CD8 T cells transferred in the experiments shown in (B) and the number of carrier mice where viremia was
absent following immune therapy are shown.
CFSE-negative indicating they had divided at least 7–10 fore, if a functional memory CD8 T cell population had
existed by d8 p.i., then 1–2  106 memory cells (5%–times (data not shown); whereas, the d8 effector cells
expanded minimally or not at all (Figure 4C). Thus, by 10% of 20 106 ) would have been transferred, and this
should have been sufficient to control viremia since asday 40 p.i., the LCMV-specific CD8 T cells could prolifer-
ate and survive in response to antigen in vivo, and con- few as 0.5  106 LCMV-specific memory CD8 T cells
from d40 p.i. were required. This strongly suggestssequently, control viral loads, whereas these properties
were not exhibited by d8 p.i. that although the precursors to memory CD8 T cells
exist in the d8 effector population they have not fullyQuantitative Perspective on Adoptive Immune
Therapy of Carrier Mice acquired the protective qualities of memory cells.
Differential TCR Signaling Capabilities in EffectorThe qualitative differences observed between d8 ef-
fector and d40memory cells in the LCMV carrier mice and Memory CD8 T Cells
To better understand why d8 effector CD8 T cells canexperiments suggest that memory cell precursors that
exist by d8 p.i. have not fully developed memory cell not proliferate and survive as well as memory CD8 T
cells when stimulated with antigen, we examined theproperties. This point is better illustrated when these
experiments are analyzed quantitatively. Typically, the ability to transduce TCR signals and to activate the
downstream mitogen-activated protein kinases ERK1number of LCMV-specific memory CD8 T cells formed
equals 5%–10% the number of effector cells at the and 2 (Extracellular signal-Regulated Kinase). ERK1/2
are ser/thr kinases that when phosphorylated translo-peak of the CD8 T cell response (d8 p.i.) (Murali-Krishna
et al., 1998). As shown in Figure 4D, 40-fold more cate to the nucleus where they activate transcription
factors involved in cell cycle regulation and effector cellLCMV-specific effector CD8 T cells were transferred
than memory cells into carrier mice (20  106 versus differentiation. The ability of P14 CD8 T cells to activate
ERK1/2 at different times postinfection was assessed0.5 106) and still the effector cell population was strik-
ingly ineffective at reducing viral levels in vivo. There- by flow cytometry using antibodies that specifically rec-
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Figure 5. Decreased Ability to Phosphorylate ERK1/2 in Activated Effector CD8 T Cells
(A and B) Phosphorylation of ERK1/2 in vivo. Thy1.1 P14 chimeric mice were infected 8, 15, 22, or 40 days previously with LCMV, were
injected with 100 g GP33-41 peptide, and the spleens were isolated 10 and 60 min later. Splenocytes were stained with Thy1.1 and phospho-
ERK1/2 (pERK) antibodies and analyzed by flow cytometry. Histograms indicate pERK1/2 fluorescence in peptide-stimulated (shaded) and
unstimulated (bold line) Thy1.1 cells and represent one of five experiments. The percent of cells containing high levels of pERK1/2 and the
mean fluorescent intensity (MFI) is indicated.
(C and D) Splenocytes were isolated from mice at the same days p.i. as in (A), but cells were stimulated with peptide for the indicated lengths
of time in vitro.
ognize phosphorylated ERK1/2 (pERK 1/2) (Chow et al., ERK1/2 as efficiently as memory CD8 T cells, but that
this property is gradually acquired over the next several2001). Mice containing Thy-1.1 P14 CD8 T cells were
infected with LCMV and 8, 15, 22, or40 days postinfec- weeks. This may account for the reduced proliferative
potential and survival observed in effector CD8 T cellstion; the cells were restimulated in vivo by injection of
GP33-41 peptide. After 10, 30, and 60 min, the spleno- in response to antigenic stimulation.
Models of Memory CD8 T Cell Differentiationcytes were fixed and stained with antibodies to Thy-1.1
and pERK1/2. After 10 min of stimulation nearly all the Elucidating the mechanisms that drive development of
memory CD8 T cells and delineating when these cellsmemory cells had high levels of pERK1/2 staining that
was sustained over the next hour, although the level of form during an immune response are answers that have
long been sought after. Two models of memory CD8 TpERK1/2 fluorescence had decreased (Figures 5A and
5B). In contrast, a smaller percentage of d8 effector cell development are described in Figure 6B. In the first
model, functional memory CD8 T cells are generated incells contained high levels of pERK1/2 and the mean
fluorescent intensity (MFI) was substantially lower, indi- the presence of antigen and exist by the peak of the
CD8 T cell response (e.g., d8 p.i. with LCMV). Thesecating that on a per cell basis d8 cells contained fewer
pERK1/2 molecules than memory cells. In addition, d8 fully formed memory cells then selectively survive the
death phase and are maintained. The second model pro-cells did not sustain pERK1/2 levels as well as memory
cells. The signaling capacity of d15 cells more closely poses memory cell precursors are generated during the
expansion phase but initially do not display functionalresembled that of d8 cells, whereas d22 cells behaved
more like memory cells. A very similar trend was ob- memory cell traits. Several weeks following antigen
clearance, however, the cells gradually acquire memoryserved when P14 CD8 T cells from days 8, 15, 22,
and 40 p.i. were stimulated with GP33-41 peptide in cell properties.
Our study heavily supports the latter model becausevitro (Figures 5C and 5D). Combined, these data suggest
that d8 effector CD8 T cells can not phosphorylate several of the salient memory cell properties examined
Delineation of Memory CD8 T Cell Development
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Figure 6. Models of Memory CD8 T Cell Development during an Immune Response
(A) Schematic illustration of the three phases of an antigen-specific CD8 T cell response following immunization.
(B) Model 1 proposes that long-lived memory CD8 T cells develop simultaneously with short-lived effector CD8 T cells during the primary
immune response in the presence of antigenic stimulation. Following antigen clearance, the short-lived effector cells die and the memory
CD8 T cells survive and are maintained. Model 2 suggests that memory CD8 T cell development occurs in two stages. First, antigenic
stimulation induces the development of effector CD8 T cells that function to eliminate the infectious pathogen. Initially following elimination
of antigen, the majority of the antigen-specific effector CD8 T cells die but the surviving memory cell precursors (in bold lines) have not yet
acquired a complete set of memory CD8 T cell phenotypes and gene expression pattern. Second, successive changes in gene expression
and other cellular processes occur over the next several weeks that gradually transform these cells into functional memory CD8 T cells that
become long-lived and can effectively respond to antigenic and homeostatic signals. Model 2 is strongly supported by the data described
herein.
here were not exhibited by the virus-specific CD8 T differences between “early” (d9) and “late” (d30) LCMV-
specific CD8 T cells (Johnson and Cole, 1975; Volkertcells until several weeks following infection. Although
d8 effector cells were cytolytic and could secrete IFN-, et al., 1974). Our present study now provides a cellular
and molecular basis for the differential behavior of anti-their ability to survive, to proliferate in response to anti-
genic and homeostatic signals, and to activate ERK1/2 gen-specific CD8 T cells at these two time points. A
detailed explanation for the behavioral differences be-was impaired compared to memory CD8 T cells (d40
p.i.). By d22 p.i., the cells behaved more like memory tween these two cell populations is provided by our
results that indicated that at d8 p.i. memory cell precur-cells indicating that memory cell qualities were being
acquired between days 8–22 p.i. Another memory CD8 sors exist but they do not display all memory cell attri-
butes.T cell phenotype that is gradually acquired is the height-
ened expression of the anti-apoptotic molecule Bcl-2. Similar to memory CD8 T cells, naı¨ve cells display a
high capacity to proliferate and to activate ERK1/2 (dataBcl-2 levels are low in LCMV-specific effector CD8 T
cells at d8 p.i., but increase by day 40 p.i. (Grayson et not shown). Thus, initially these properties are intrinsic
to CD8 T cells but after prolonged antigenic stimulational., 2000). The gene expression analysis done in this
study also revealed that the profile of gene expression these functions become impaired. This phenomenon,
previously termed antigen-induced non responsivenessof memory CD8 T cells differs from that of d8 effector
cells and demonstrated that the expression of many (AINR), has been observed in other experimental sys-
tems (Bikah et al., 2000; Deeths et al., 1999). Our resultsgenes changes between d8-40 p.i. Further examination
of these genes may identify key signals involved in mem- demonstrate that in vivo AINR is transient and that mem-
ory cell precursors regain the ability to respond to anti-ory CD8 T cell differentiation. Nearly 30 years ago, clas-
sic studies in the LCMV model had noted functional gen. How the T cells responses are “reset” is not clear,
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was synthesized using SuperScript Choice cDNA synthesis kitbut may be linked to the ability to transduce and sustain
(GIBCO/BRL) and an oligo(dT) primer containing a T7 promoter. TheTCR signals. Also, regaining responsiveness may re-
MEGAscript T7 kit (Ambion, Austin, TX) was used to amplify cRNAquire a period of rest from antigen because under contin-
from the cDNA. The cRNA was reverse transcribed with either Cy3
uous antigenic stimulation, such as during chronic viral or Cy5 fluorescently labeled nucleotides and hybridized on mouse
infections and malignant melanomas, virus-specific T GEM 1 microarrays at Incyte Genomics (St. Louis, MO) as described
in Yue et al., (2001). Samples compared: naı¨ve versus d8 effectorcells often are deleted or become dysfunctional and
(n 	 3) or memory cells (n 	 3) or d15 (n 	 2) or d22 cells (n 	 2).lose effector functions (Lee et al., 1999; Zajac et al.,
Expression pattern clusters were defined using hierarchical tree1998). It is not clear if long-lived, functional memory CD8
and K-means clustering algorithms in J-Express v. 1.1 (Dysvik andT cells can be generated under these conditions.
Jonassen, 2001). Hybridization of biotin-labeled cRNA to Affymetrix
Characterization of a gene expression profile of func- U74A chips occurred according to manufacturer’s protocols and
tional memory CD8 T cells will hopefully aid discovery similar to that described (Teague et al., 1999).
of the mechanisms that regulate development and main-
Western Blottingtenance of these cells, which would prove invaluable
Protein lysates from 1  106 FACS sorted naı¨ve, d8 effector, andfor optimizing vaccination. Moreover, comparing gene
memory P14 Thy1.1 CD8 T cells were resolved by SDS-PAGE.expression profiles of functional and dysfunctional CD8
Granzyme B was detected by Western blotting using rabbit anti-
T cells may uncover the source of effector cell dysfunc- granzyme B antibodies at 1:1000 (a gift of Dr. Tim Ley, Washington
tion that, in turn, could lead to novel immunotherapeutic University, St. Louis, MO).
approaches to fight chronic infections and tumors. Also,
Antigen-Driven and Homeostatic Proliferation Assaysdelineating when memory CD8 T cells form in vivo and
For in vitro proliferation assays P14 CD8 T cells from infected miceacquire a high proliferative capacity has considerable
were isolated at 8, 15, 22, or greater than 40 days p.i. and culturedimplications for vaccine regimens that involve boosting
with GP33-41 peptide as previously described (Kaech and Ahmed,
for efficacy, because our results suggest that vaccine 2001). In LCMV carrier mice, splenocytes from Thy1.1 B6 mice
boosters should be separated by a significant length of infected 8 and 40 days previously were CFSE-labeled and adop-
time to allow the effector cells generated to differentiate tively transferred separately into LCMV carrier mice and analyzed
4 and 7 days later. A total of 1  106 DbGP33-41 and DbNP396-404-into memory cells and reset their responsiveness to anti-
specific CD8 T cells from each population were transferred. Forgen. Finally, it is tempting to speculate about similarities
homeostatic proliferation assays, splenocytes from P14 chimericbetween immunological and neuronal memory and
mice infected 8, 15, 22, or 40 days previously with LCMV were
whether common molecular mechanisms may be in- CFSE-labeled and transferred into naı¨ve, non-irradiated C57BL/6
volved in regulating these two types of “memory”. hosts. The donor cells were examined 1, 11, and 30 days post-
transfer.
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